Research Topics
| M M KitahataSummaryAffiliation: University of Washington Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Electronic human immunodeficiency virus (HIV) clinical reminder system improves adherence to practice guidelines among the University of Washington HIV Study CohortMari M Kitahata
Department of Medicine, University of Washington, Harborview Medical Center, Box 359931, 325 9th Ave, Seattle, WA 98104, USA
Clin Infect Dis 36:803-11. 2003..86; 95% CI, 1.05-3.27; P=.03) and syphilis infection (OR, 3.71; 95% CI, 2.37-5.81; P<.0001). HIV clinical reminders delivered at the time that HIV care is provided were associated with more timely initiation of recommended practices...
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical SystemsMari M Kitahata
Department of Medicine, University of Washington, Seattle, 98195, USA
Int J Epidemiol 37:948-55. 2008- CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?Keri N Althoff
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA
AIDS Res Ther 7:45. 2010..10%, respectively). Due to the increasing proportion, consistently lower CD4 counts, and more advanced HIV disease in adults ≥50-year-old at first presentation for HIV care, renewed HIV testing efforts are needed... - Physician experience in the care of HIV-infected persons is associated with earlier adoption of new antiretroviral therapyM M Kitahata
Department of Medicine, University of Washington, Seattle, USA
J Acquir Immune Defic Syndr 24:106-14. 2000..We conducted this study to determine whether greater physician experience is associated with earlier adoption and appropriate use of new antiretroviral treatment regimens... - Effect of early versus deferred antiretroviral therapy for HIV on survivalMari M Kitahata
University of Washington, Harborview Medical Center, 325 Ninth Ave, Box 359931, Seattle, WA 98104, USA
N Engl J Med 360:1815-26. 2009..The optimal time for the initiation of antiretroviral therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection is uncertain... - Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and deathMari M Kitahata
Department of Medicine, University of Washington, Seattle, Washington 98104, USA
Int J STD AIDS 15:803-10. 2004..2). Patients who progressed to AIDS or death had significantly higher viral loads (P = 0.01) and lower CD4 cell counts (P = 0.03) than patients who experienced virologic failure, but did not progress... - Primary care delivery is associated with greater physician experience and improved survival among persons with AIDSMari M Kitahata
Department of Medicine, University of Washington, Seattle, Wash, USA
J Gen Intern Med 18:95-103. 2003..It has been shown that greater physician experience in the care of persons with AIDS prolongs survival, but how more experienced primary care physicians achieve better outcomes is not known... - Comprehensive health care for people infected with HIV in developing countriesMari M Kitahata
Center for AIDS and STD, University of Washington, Harborview Medical Center, 325 9th Avenue, Seattle, WA 98104, USA
BMJ 325:954-7. 2002 - Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophyH M Crane
Center for AIDS and STD Research, Harborview Medical Center, University of Washington, Seattle, WA 98104, USA
HIV Med 9:780-6. 2008..We sought to determine the association between body morphology abnormalities and depression, examining lipoatrophy and lipohypertrophy separately... 
The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individualsMary K Tegger
Department of Medicine, University of Washington, Seattle, Washington, USA
AIDS Patient Care STDS 22:233-43. 2008..Screening for these disorders in primary care settings and access to appropriate treatment are increasingly important components of providing care to HIV-infected patients...- Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical responseHuong Q Nguyen
Department of Epidemiology, University of Washington, Seattle, Washington, USA
AIDS 22:937-45. 2008..To evaluate the role of highly active antiretroviral therapy and chemotherapy on tumor response among persons with AIDS-related Kaposi sarcoma and identify factors associated with response in a clinic setting... - Optimal timing of routine vaccination in HIV-infected personsHeidi M Crane
Center for AIDS and STD Research, University of Washington, Harborview Medical Center, Box 359931, 325 9th Avenue, Seattle, WA 98104, USA
Curr HIV/AIDS Rep 6:93-9. 2009..However, risks of delaying vaccination include that the patient may be exposed to the pathogen or lost to follow-up before vaccination. We review recent studies on the timing of routine vaccination of HIV-infected individuals... - Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical careHeidi M Crane
University of Washington, Seattle, Washington, USA
AIDS 25:185-95. 2011..to assess the associations between nucleoside reverse transcriptase inhibitors (NRTIs) and change in lipid levels among a large cohort of HIV-infected patients in routine clinical care initiating their first potent antiretroviral regimen... - Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected personsH Nina Kim
Department of Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA
Int J STD AIDS 19:600-4. 2008..033), after adjusting for these other covariates. Our findings underscore the importance of confirming seroconversion after HB vaccination in HIV-infected patients and initiating vaccination early in the course of HIV infection... - When to start antiretroviral therapyMari M Kitahata
University of Washington School of Medicine, Seattle, WA, USA
Top HIV Med 18:121-6. 2010..Kitahata, MD, MPH, at the International AIDS Society-USA continuing medical education programs held in November 2009 in New York City and May 2010 in San Francisco. The original presentations are available as Webcasts at www.iasusa.org... - Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapineHeidi M Crane
Department of Medicine, University of Washington, Seattle, Washington, USA
AIDS Patient Care STDS 21:920-9. 2007.... - Diabetes case identification methods applied to electronic medical record systems: their use in HIV-infected patientsHeidi M Crane
Department of Medicine, University of Washington, Seattle, USA
Curr HIV Res 4:97-106. 2006..Accurately identifying HIV-infected patients with a diagnosis of diabetes in electronic medical record systems will facilitate the study of patients with this disease... - A single-item measure of health-related quality-of-life for HIV-infected patients in routine clinical careHeidi M Crane
Department of Medicine, University of Washington, Seattle, Washington 98104, USA
AIDS Patient Care STDS 20:161-74. 2006..EVGGFP can be used to assess health status among HIV-infected patients in routine clinical care and may be useful in settings in which comprehensive HRQL assessment is not practical... - HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variabilityMargaret C Shuhart
Department of Medicine, University of Washington, Seattle, USA
J Infect Dis 193:1211-8. 2006..The effects of human immunodeficiency virus (HIV) coinfection and highly active antiretroviral therapy (HAART) on HCV quasispecies variability have not been firmly established... - Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapyHeidi M Crane
Department of Medicine, Center for AIDS and STD Research, University of Washington, Harborview Medical Center, 325 9th Avenue, Seattle, WA 98104, USA
AIDS 20:1019-26. 2006..To examine the effect of antiretroviral agents and clinical factors on the development of elevated blood pressure (BP)... - Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patientsHeidi M Crane
The Department of Medicine, University of Washington, Seattle, Washington, USA
Curr HIV Res 5:109-18. 2007..We examined the feasibility of using a web-based application on tablet PCs with touch screens to collect PROs in a busy, multi-provider, outpatient HIV clinical care setting... - Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovirHeidi M Crane
Department of Medicine, University of Washington, Seattle, Washington 98104, USA
AIDS 21:1431-9. 2007..To examine the effect of antiretroviral agents and clinical factors on the development of tenofovir-associated kidney dysfunction... - Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIVB J Feldman
Department of Medicine, Harborview Medical Center, University of Washington, 325 9th Ave, Box 359931, Seattle, WA 98104, USA
AIDS Behav 17:307-18. 2013..These results and the SRSI's low patient burden suggest its routine use could be helpful for assessing adherence in clinical care and should be more widespread, particularly where more complex instruments may be impractical... - Lipoatrophy and lipohypertrophy are independently associated with hypertensionHeidi M Crane
Department of Medicine, University of Washington, Seattle, WA 98104, USA
HIV Med 10:496-503. 2009..Lipoatrophy and lipohypertrophy are associated with metabolic abnormalities, but little is known about their impact on hypertension. We conducted this study to determine the associations of lipoatrophy and lipohypertrophy with hypertension... - Measuring depression levels in HIV-infected patients as part of routine clinical care using the nine-item Patient Health Questionnaire (PHQ-9)P K Crane
Department of Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA
AIDS Care 22:874-85. 2010.... - Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)Stephen J Gange
NA-ACCORD Coordinating Center, Baltimore, MD 21287, USA
Int J Epidemiol 36:294-301. 2007 - Tenofovir-associated decline in renal functionHeidi M Crane
J Infect Dis 198:937; author reply 937-8. 2008 - Blood pressure and antiretroviral therapyHeidi M Crane
AIDS 21:1992-3. 2007 - Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapyPeter W Hunt
Positive Health Program, San Francisco General Hospital, University of California, San Francisco, California, USA
AIDS 17:1907-15. 2003..The immune system's capacity for CD4 T lymphocyte restoration is not limited by low pre-therapy CD4 counts...
Research Grants
- ANTIRETROVIRAL THERAPY AND LONG-TERM CLINICAL OUTCOMESMari Kitahata; Fiscal Year: 2003....